Saeed F, Berchuck JE, Bilen MA, Gandhi JS, et al. Optimizing treatment for metastatic castration-resistant prostate cancer: Food 
and Drug Administration-approved therapies, emerging strategies, and 
biomarker-driven approaches. Cancer 2025;131:e70037.
PMID: 40782341
|   |  |  | 
